Bioment

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Bioment

Bioment is a prescription-only medicine primarily used to combat bacterial infections throughout the body. It is formally classified as an antibiotic combination and is known internationally by the generic name Co-amoxiclav, which is the fixed-dose pairing of its two primary components. This medicine belongs to the pharmacological class of Antibacterial agents for systemic use, specifically the group of penicillins combined with beta-lactamase inhibitors.


Property Description
Active ingredients Amoxicillin, Clavulanic acid
Forms Tablets, Oral Suspension, Injectable Powder
Pharmacological class Penicillins + beta-lactamase inhibitors
Common purpose Combating systemic bacterial infections
Origin Synthetic/Semisynthetic

What Type of Medicine is Bioment? (Definition and Classification)

Bioment, which is a specific brand formulation of Co-amoxiclav, is a fixed-dose combination product designed to enhance antibacterial action beyond that of a single agent. This composition structurally joins the core antibiotic, Amoxicillin, with a protective agent, Clavulanic acid, to overcome evolving bacterial defenses. The combination is clinically recognized for its effectiveness in treating infections caused by beta-lactamase-producing organisms. The medicine is often provided in a variety of dosage forms optimized for different patient groups, including oral suspension options tailored for pediatric patients.

Composition and Physical Forms Available (Ingredients and Presentation)

The two essential active ingredients in Bioment are the beta-lactam antibiotic Amoxicillin and the beta-lactamase inhibitor Clavulanic acid (often used as potassium clavulanate). The medicine is manufactured in multiple pharmaceutical preparations for both oral and intravenous administration. These readily available dosage form(s) include various types of tablets (such as film-coated and dispersible versions), as well as preparations that can be reconstituted into an oral suspension or a powder for injection or infusion. This medicine is crucial for treating infections where bacteria produce resistance enzymes, as the dual-agent approach is vital for maintaining treatment success against these difficult-to-treat infections.

What is the General Purpose of Bioment? (High-Level Benefit)

The general therapeutic purpose of Bioment is to maintain a potent, broad-spectrum antibiotic effect against a wide range of clinically relevant bacteria. While Amoxicillin provides the core bactericidal action by targeting the bacterial cell wall, the integral addition of Clavulanic acid ensures the medicine remains effective. Clavulanic acid achieves this by safeguarding the Amoxicillin from degradation by bacterial beta-lactamase enzymes, thereby sustaining the antibiotic's potency against resistant strains, a mechanism essential for treating common but serious conditions like certain respiratory tract infections.

What side effects are possible with Bioment?

Possible Side Effects and Safety Information for Bioment

This section outlines officially documented safety information and adverse reactions associated with the active ingredients commonly found in Bioment-branded pharmaceutical products, based on governmental regulatory summaries.

Adverse Reaction Scope

Classification Examples of Known Adverse Reactions
Very Common Gastrointestinal disturbances (diarrhea, nausea, vomiting, metallic taste), headache, upper respiratory tract infections.
Serious/Clinically Significant Lactic acidosis (a medical emergency), severe allergic reactions (anaphylaxis), signs of liver inflammation (hepatitis), and heart failure (especially in patients with pre-existing risk factors).
Population-Specific Safety Contraindicated in patients with severe kidney impairment or certain heart conditions (e.g., severe heart failure). Use in pregnancy and breastfeeding is generally not recommended and requires specialist guidance. Caution is required in elderly patients due to potentially increased risks of bone fracture and bladder cancer (associated with pioglitazone-containing products).
Exposure- or Dose-Related Risk of lactic acidosis is increased in situations of acute kidney injury, dehydration, or excessive alcohol intake. The potential for hypoglycemia (low blood sugar) may be present depending on the combination of active ingredients.

Safety-Related Restrictions

Bioment-branded products containing metformin are contraindicated in conditions predisposing to lactic acidosis, including acute or chronic metabolic acidosis, severe renal impairment, and severe infections. Products containing pioglitazone may be restricted in patients with a history of bladder cancer or uninvestigated gross hematuria.

Regulatory authorities require immediate reporting of all serious and unexpected adverse reactions to the relevant Pharmacovigilance Centre for continuous safety monitoring. The official safety classification framework (e.g., EMA/ICH frequency bands) is used to communicate the likelihood of these events to healthcare professionals and patients.

Overdose and Emergency Response

The official regulatory profile for Bioment (Co-amoxiclav) documents overdose manifestations that primarily involve the gastrointestinal and urinary systems. Reported presentations include general gastrointestinal symptoms and disturbances in fluid and electrolyte balances. More specifically, overdose may be associated with Amoxicillin crystalluria, a physiological finding that can lead to renal failure and is clinically evidenced by decreased urination or the presence of cloudy or bloody urine.

A major concern described in the official labeling is the risk of convulsions (seizures). This severe outcome is explicitly noted to occur in patients with impaired renal function or in those who have received high doses of the medicine. Regulatory guidance mandates specific actions in severe scenarios. Urgent medical attention is required, and users must contact emergency services immediately if the person experiences a seizure, exhibits trouble breathing, or has collapsed.

Management procedures focus on supportive treatment. The regulatory documents confirm that no specific antidote is known, and recommended measures include symptomatic treatment for gastrointestinal effects and ensuring adequate fluid intake to reduce the risk of crystalluria. Haemodialysis is officially recognized as a procedural measure for assisting in the removal of the active ingredients from the circulation.

Therapeutic Uses of Bioment

What Bioment Treats: Main Uses and Benefits

Bioment is commonly used across conditions presenting with acute or disruptive episodes where symptoms create noticeable physiological strain. The medication is applicable in clinical settings that involve infections of the respiratory tract (like community-acquired pneumonia and sinusitis), the genitourinary tract (such as pyelonephritis), and skin and soft tissues (like cellulitis). It helps address symptom clusters that may become intense or disruptive in these major therapeutic domains.

The drug is often used during phases when symptoms become more noticeable, such as severe ear pain in otitis media or swelling and redness in a spreading soft tissue infection. The key therapeutic purpose is to provide additional symptomatic support that helps ease symptoms that interfere with daily functioning, like painful urination or acute respiratory distress.

Quick Fact: Relief for Acute Discomfort

Quick Fact: Relief for Acute Discomfort in the sinuses, ears, and urinary tract. It supports the patient during difficult episodes by easing the overall symptom load.

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Bioment — official regulatory information

Category Official Regulatory Statement
Populations for whom use is contraindicated Patients with a history of serious hypersensitivity reaction to penicillins or other beta-lactam antibiotics. Patients with a prior history of cholestatic jaundice or hepatic dysfunction specifically associated with Amoxicillin/Clavulanate use.
Conditions where use is avoided The medicine should be avoided in patients with suspected or confirmed Infectious Mononucleosis.
Age-related eligibility rules Use is established in Neonates and Infants (under 3 months), but requires a modified administration interval. The extended-release tablet is not established for pediatric patients weighing less than 40 kg. Older adults typically require no adjustment unless renal impairment exists.
Condition-specific eligibility rules Patients with severe renal impairment (creatinine clearance < 30 mL/min) are subject to conditional use and often require dosage adjustment. Specific high-dose tablet forms are contraindicated in this patient group.
Pregnancy and lactation eligibility status Pregnancy use is allowed only if clearly needed. Caution must be exercised during lactation as Amoxicillin is excreted into breast milk.
Eligibility-related restrictions Patients with hepatic impairment must use the medicine with caution and are advised to monitor liver function. Specific oral forms containing aspartame should be avoided by patients with Phenylketonuria (PKU).

Connection to the overall eligibility profile

Official regulatory documents establish who can and cannot use Bioment by defining non-negotiable absolute contraindications based on allergy history and prior liver reactions, which formally prohibit use in these groups. For otherwise eligible adults and children, regulators impose further conditional restrictions based on the patient's existing organ function, metabolic disorders, and age, ensuring specific population safety guidelines are followed according to label.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documentation structures the interaction profile of Bioment (Metformin-containing products) based on the co-administration's effect on drug exposure and pharmacological outcomes. The following categories and substance classes are officially cited as having documented interactions.

Interaction Scope

Substance Category
Other Anti-diabetic Medications (e.g., Insulin, Sulfonylureas)
Diuretics (e.g., Furosemide)
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and COX-2 Inhibitors
Sympathomimetics (e.g., Salbutamol, Terbutaline)

Interaction-Related Constraints and Classification

The most clinically relevant interactions are those that may cause a significant change in blood sugar levels or increase the risk of a serious, specific adverse condition.

  • Pharmacodynamic Interaction: Combining Bioment with other anti-diabetic medications is documented to increase the likelihood of low blood sugar (hypoglycemia) due to combined therapeutic effects.
  • Risk-Amplifying Combinations:
    • Alcohol Consumption: Concurrent use with alcohol is officially linked to an increased risk of lactic acidosis and is advised to be avoided.
    • Iodine-Containing Contrast Medium: For specific diagnostic X-ray or scan procedures, administration of Bioment must be temporarily stopped before or at the time of injection of iodine-containing contrast media, as stated in regulatory documents.

These official statements define the required restrictions for use, establishing boundaries for co-administration with medicinal products and non-medicinal substances like alcohol or specific diagnostic agents.

Mechanism of Action

Co-amoxiclav (Bioment) exerts a bactericidal effect through a dual, chemically interdependent mechanism, focusing on both the bacterial structure and its defense system.

Irreversible Disruption of Bacterial Cell Wall

The primary component, Amoxicillin, acts as a suicidal inhibitor that permanently binds to and disables Penicillin-Binding Proteins (PBPs) in the bacterial cell membrane. By preventing these key enzymes from performing the final cross-linking step of peptidoglycan biosynthesis, the drug causes the new cell wall to be structurally unsound. This disruption of the bacterial cell's architecture leads to an inability to withstand osmotic pressure, initiating autolysis and resulting in cell death. This mechanism directly contributes to the core physiological consequence of eliminating viable bacterial cells.

Targeted Inactivation of Bacterial Resistance Enzymes

The second component, Clavulanic acid, restores the efficacy of Amoxicillin by specifically neutralizing the bacteria's defense mechanism: the beta-lactamase enzymes. Clavulanic acid is an irreversible inhibitor that binds to and chemically inactivates these enzymes, preventing them from hydrolyzing the Amoxicillin molecule. This targeted protection mechanism ensures that a high, active concentration of Amoxicillin is sustained to reach the PBPs, allowing for the restoration of Amoxicillin's bactericidal activity against otherwise resistant bacterial strains.

Dosage and Administration Information

How to Use Bioment (Co-amoxiclav): Administration Guidelines

Bioment is an antibiotic combination administered according to established principles to ensure proper application.


Administration and Dosage Principles

The medicine is used via two primary routes of administration: Oral (using tablets or reconstituted suspension) and Intravenous (IV) (using powder for injection or infusion). The IV route is typically utilized for initiating treatment in more severe infections, with a transition to the oral form when the patient's condition permits, a process known as an IV-to-oral switch.

Oral Bioment is taken at the start of a meal. This specific timing is utilized to reduce potential gastrointestinal discomfort and optimize the absorption of the clavulanic acid component. Dosing is structured into regimens, typically administered two to three times per day, ensuring the doses are evenly spaced to maintain consistent levels.


Duration and Special Dosing Instructions

Treatment with Bioment is generally short-term, and the duration of therapy should not exceed 14 days without a formal review of the patient's status by a healthcare professional.

Specific dosing modifications are used for certain patient populations:

  • Renal Impairment: For patients with reduced kidney function (creatinine clearance le 30 mL/min), the dose or the interval between doses is adjusted to prevent accumulation of the drug components.
  • Pediatric Use: For children under 40 kg, the dosage is calculated based on body weight (mg/kg/day) using the oral suspension form.

If a dose is missed, it should be taken as soon as possible, but double doses must not be taken. The intravenous preparation is administered via a slow infusion over 30 to 40 minutes in a controlled clinical setting.

Recent Clinical Evidence

Research evidence / Overview of studies for Bioment

Evidence for Infections of the Lungs and Sinuses (Respiratory Tract)

The use of this antibiotic combination in the context of Community-Acquired Pneumonia (CAP), a lower respiratory infection, has been the subject of formal research evaluation for many years. The research primarily involves large Randomized Controlled Trials (RCTs) and comparative trials, which research examined how this medicine was observed in adult populations, including older adults, often during periods of increased symptom activity requiring hospitalization. These studies focused on outcomes related to systemic or functional imbalance, specifically measuring endpoints such as the time to change in fever and cough, and the length of hospital stay. Findings describe patterns observed in the studies that compared Bioment with other standard antibiotics, contributing to the research understanding of systemic antibacterial use.

For Acute Bacterial Rhinosinusitis (sinus infections), the clinical evaluation for this indication largely relies on data that address certain types of resistant bacteria that may be present in the sinuses. However, certainty remains low due to the reliance on evidence derived from broader respiratory infection studies, and comparative evidence is lacking against all potential alternative treatments for this specific condition.

Evidence for Acute Otitis Media (Ear Infections) in Pediatric Patients

A significant body of research, heavily supported by Randomized Controlled Trials (RCTs), was evaluated in children with Acute Otitis Media (AOM). Studies monitored pediatric patients with conditions associated with acute or disruptive episodes. Research examined outcomes related to physical discomfort, such as the time to change in clinical symptoms like fever and ear pain, and the rate of subsequent recurrence. The research has also explored the patterns associated with different dose ratios of the two active ingredients in relation to these outcomes.

Long-Term Evidence and Research Gaps

Most of the available evidence for Bioment, particularly the core RCTs, focuses on short-term outcomes relevant in trials assessing short-term or episodic symptom patterns. Long-term effects are not fully established, and there is limited data to describe the durability of the response or the potential for symptom recurrence over many months or years. Additionally, while the research has explored the medicine’s profile in pediatric patients and older adults, data for certain groups remain insufficient. For example, specific evidence in patients with complex or rare comorbidities is often limited, relying instead on data gathered from broader, general studied populations. Overall, the evidence quality varies across studies based on the indication, and research is ongoing in many areas.

Frequently Asked Questions (FAQ)

Common questions about Bioment (FAQ)

Q: Can Bioment be taken long-term for chronic conditions?

Regulatory documents state that treatment duration for Bioment should not typically exceed 14 days. If a longer period is required, a formal review of the patient's status by a healthcare professional is typically conducted to assess the need for continued therapy.


Q: What are the signs that Bioment might not be agreeing with me?

Adverse reactions such as diarrhea, nausea, vomiting, or headache are commonly reported. However, official safety data also notes serious reactions, including signs of severe allergic reactions or liver inflammation. If you experience any new, unusual, or worsening symptoms, seeking guidance from a healthcare professional is appropriate.


Q: Are there any blood tests required before or during treatment with Bioment?

Official precautions advise that liver function should be monitored for patients who have existing hepatic impairment or if the medicine is used for a prolonged period. Whether specific blood tests are needed for routine treatment is determined by the prescribing healthcare professional.


Q: Why do some people take Bioment in the morning and others at night?

Bioment is typically administered two to three times per day, with doses evenly spaced. This schedule helps maintain consistent levels of the medicine in the body. The specific timing (e.g., morning or evening) is also related to the instruction that the dose should be taken at the start of a meal.


Q: Is it okay to take over-the-counter pain relievers like acetaminophen with Bioment?

The official interaction profile lists specific drug classes that can interact with Bioment, such as certain NSAIDs. While acetaminophen (a non-NSAID) is not specifically listed as a known interaction, consulting a healthcare professional before combining Bioment with any other over-the-counter medicine is important.


Q: What are the less common, but serious side effects of Bioment I should know about?

Official safety information lists serious reactions that may require immediate attention, even if they are less common. These include severe allergic reactions (anaphylaxis), signs of liver problems (hepatitis), and severe, persistent diarrhea (antibiotic-associated colitis). These are detailed in the official safety documents.


Q: Why is Bioment sometimes prescribed with another medication?

Bioment is already a fixed-dose combination containing an antibiotic (Amoxicillin) and a protective agent (Clavulanic acid). If a healthcare provider prescribes additional medication, it is typically to address a co-existing medical condition, target different types of pathogens, or manage specific symptoms.


Q: Can Bioment affect birth control pills?

Regulatory information indicates that hormonal oral contraceptives may be less effective when taken concurrently with Bioment. Discussion of this potential interaction with a healthcare professional, as well as considering additional non-hormonal methods of contraception, is noted in safety guidance.


Q: What's the mechanism of action of Bioment in simple terms?

Bioment works through a dual action. The primary component, Amoxicillin, kills bacteria by disrupting the formation of their cell walls. The second component, Clavulanic acid, protects the Amoxicillin from being destroyed by the bacteria’s natural defenses, ensuring the antibiotic can remain effective.


Q: Can Bioment be crushed or split if it's not a coated pill?

Official product information specifies that certain dosage forms, such as the extended-release tablet, must not be crushed or chewed. For other tablet types and formulations, the product's patient information leaflet contains specific instructions on preparation that should be followed.


Q: Does Bioment help with pain, or only the underlying condition?

Bioment is formally classified as an antibiotic and is indicated for the treatment of susceptible bacterial infections. While eliminating the underlying infection may indirectly relieve pain, the medicine is not officially indicated as a primary treatment for pain relief.


Q: How quickly should I expect to feel the effects of Bioment?

Clinical studies often measure therapeutic response based on the reduction of symptoms like fever or cough. Individual patient response times, however, can vary. Adherence to the full prescribed course is important, even if the patient begins to feel better quickly, to support the complete clearance of the infection.


Q: Can taking Bioment affect sleep patterns?

Official safety data lists central nervous system (CNS) effects, such as dizziness and headache. While specific sleep disturbances are generally not listed as a common reported effect, any unusual changes to sleep warrant discussion with a healthcare professional.


Q: Do older adults need a lower dose of Bioment generally?

Older adults usually require no specific dosage adjustment for Bioment. However, if they have evidence of reduced kidney function (renal impairment), the dose or dosing interval must be formally modified by a healthcare professional.


Q: What is the research evidence for Bioment in treating [condition A]?

Bioment is officially approved for treating a specific list of bacterial infections caused by susceptible organisms. Its use for conditions that are not listed in the official indications is considered off-label and is not supported by regulatory evidence.


Q: Has Bioment been studied in pediatric populations?

Yes, the use of Bioment is established in infants and children (pediatric patients). Dosage for children is precisely calculated based on body weight, and special administration intervals are required for neonates and infants under three months of age.


Q: Can Bioment cause stomach upset, and how can I minimize it?

Gastrointestinal disturbances, including diarrhea, nausea, and vomiting, are listed as very common side effects. Official instructions state that the oral form of Bioment is taken at the start of a meal, which is intended to help reduce potential stomach discomfort.


Q: What kind of studies have been done on Bioment's long-term safety?

The primary clinical evidence for Bioment focuses on short-term outcomes, which align with the typical short course of treatment (up to 14 days). Regulatory documents indicate that data on the long-term safety of the medicine over many months or years is limited.


Q: Is it common for people to stop taking Bioment due to side effects?

Official safety documents classify side effects by their expected frequency, such as 'very common' (e.g., diarrhea) or 'common.' The regulatory text provides the likelihood of experiencing a side effect, but it does not specify a concrete rate or percentage of patients who discontinue treatment.


Q: How long does Bioment stay in your system after the last dose?

The pharmacokinetic data provided in regulatory documents shows that the half-life for both Amoxicillin and Clavulanic acid is approximately one hour. This figure is used to determine the correct dosing interval, but the complete elimination of all drug traces takes a longer period.


Q: Is there a generic version of Bioment available?

Bioment is a specific brand name for the fixed combination of Amoxicillin and Clavulanic acid (Co-amoxiclav). Generic versions of this combination are available under the name Amoxicillin/Clavulanate potassium.


Q: What happens when Bioment is discontinued?

Regulatory guidance emphasizes the importance of completing the full prescribed course of Bioment to ensure the infection is fully eliminated. Official regulatory documents focus on adherence to the full course and do not specifically address drug withdrawal or rebound effects upon completion of treatment.


Q: Are there different strengths or formulations of Bioment?

Yes, Bioment is available in multiple pharmaceutical preparations, including various tablet strengths, oral suspensions, and a powder for injection or infusion. These different forms and strengths are optimized for different patient groups and administration routes.


Q: Do people develop a tolerance to Bioment over time?

The Clavulanic acid component is specifically included to protect the Amoxicillin from degradation by bacterial enzymes. Since the development of antibiotic resistance is a known risk, adherence to the full course is stressed to support the medicine's continued efficacy.


Q: Can Bioment worsen anxiety or mood swings?

Official adverse reaction lists include disorders of the nervous system. While specific psychological effects like worsening anxiety or mood swings are generally not listed as commonly reported side effects, any new or concerning changes should be discussed with a healthcare professional.


Q: What are common patient experiences when starting Bioment?

Common patient experiences are generally linked to the Very Common adverse reactions listed in the official safety information. These include mild gastrointestinal disturbances like diarrhea, nausea, and vomiting, as well as headaches.


Q: Is Bioment a high-risk medication for liver issues?

Bioment is formally contraindicated (not to be used) in patients with a prior history of liver problems (cholestatic jaundice or hepatic dysfunction) specifically caused by its use. Caution and monitoring are also required for patients with pre-existing hepatic impairment.


Q: What percentage of people experience side effects with Bioment?

Regulatory documents categorize the frequency of side effects using standardized classification bands, such as 'very common' (e.g., affecting 1 in 10 patients) or 'common.' They do not provide a single overall percentage that represents the incidence of all side effects combined.


Q: Is Bioment safe to use during the flu or a mild cold?

Bioment is an antibiotic and is officially indicated only for the treatment of infections caused by susceptible bacteria. It is not effective against viral infections like the flu or a mild cold.

How should Bioment be stored and disposed of?

How to Store and Dispose of Bioment

Bioment must be stored according to specific regulatory requirements to maintain its stability and effectiveness. Solid dosage forms, such as tablets and the dry powder for suspension, must be stored at room temperature, typically between 68°F and 77°F (20°C to 25°C). The medicine must be kept in its original, tightly closed container and protected from light and moisture.

Stability and Child Safety

If the oral suspension is reconstituted, it must be stored in the refrigerator (36°F to 46°F) and discarded after 10 days; this liquid form must not be frozen. It is mandatory to keep Bioment out of the sight and reach of children.

Disposal Requirements

Any unused or expired Bioment must not be disposed of in household waste or wastewater (sinks or toilets). Disposal must follow local regulatory requirements, often involving pharmaceutical take-back programs.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Bioment found in:

A-Z Index: